Sitemap > Breaking Research > Metabolic & Hormonal Disorders
Displaying 701 - 750 of 3753 results
- Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects.
- HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients.
- Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
- Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina.
- Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity.
- Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.
- Impairment of cardiac function in hypertensive patients with Type 2 diabetes: a LIFE study.
- Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes.
- The effect of manipulation of basal pulsatile insulin on insulin action in Type 2 diabetes.
- Clustering of protective factors for glucose intolerance and insulin resistance: a cross-sectional study.
- Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus.
- Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread.
- Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats.
- Insulin resistance and risk of congestive heart failure.
- Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.
- Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
- Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat.
- Prevention of oxidative stress by adenoviral overexpression of glutathione-related enzymes in pancreatic islets.
- Pathological roles of advanced glycation end product receptors SR-A and CD36.
- Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand.
- The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse.
- Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
- Adamantyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
- Role of PYK2 in the development of obesity and insulin resistance.
- Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts.
- A novel insulin delivery algorithm in rats with type 1 diabetes: the fading memory proportional-derivative method.
- Establishment of a diabetic mouse model with progressive diabetic nephropathy.
- HST2 mediates SIR2-independent life-span extension by calorie restriction.
- The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
- Rosiglitazone protects against ischemia/reperfusion-induced leukocyte adhesion in the zucker diabetic fatty rat.
- The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.
- Cdk5-dependent regulation of glucose-stimulated insulin secretion.
- NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
- Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.
- Agouti-related peptide-expressing neurons are mandatory for feeding.
- IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism.
- Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
- Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonists.
- Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
- Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
- In vitro aldose reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones.
- Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists.
- Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
- Estimated risks for developing obesity in the Framingham Heart Study.
- Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17.
- Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).
- Apolipoprotein-mediated pathways of lipid antigen presentation.
- Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease.
- Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.
- Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 Next >